AI
TECH icon

Accredited Investors’s Bio-Techne TECH Stock Holding History

Accredited Investors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390K Sell
5,521
-20
-0.4% -$1.08K 0.02% 202
2026
Q1 		$290K Sell
5,541
-511
-8% -$30.7K 0.02% 224
2025
Q4 		$356K Buy
6,052
+161
+3% +$9.78K 0.02% 199
2025
Q3 		$328K Sell
5,891
-1,107
-16% -$59.3K 0.02% 189
2025
Q2 		$360K Buy
6,998
+806
+13% +$40.5K 0.02% 168
2025
Q1 		$363K Buy
6,192
+465
+8% +$31.5K 0.02% 156
2024
Q4 		$412K Buy
5,727
+1,363
+31% +$100K 0.02% 148
2024
Q3 		$349K Buy
4,364
+4
+0.1% +$301 0.02% 160
2024
Q2 		$312K Sell
4,360
-896
-17% -$65.9K 0.02% 157
2024
Q1 		$370K Sell
5,256
-991
-16% -$70.9K 0.02% 146
2023
Q4 		$482K Sell
6,247
-174
-3% -$11.5K 0.03% 125
2023
Q3 		$437K Buy
6,421
+2,779
+76% +$220K 0.03% 120
2023
Q2 		$297K Buy
+3,642
New +$293K 0.02% 148
2017
Q2 		– Sell
-8,400
Closed -$213K – 112
2017
Q1 		$213K Buy
+8,400
New +$217K 0.05% 100
2016
Q4 		– Sell
-8,400
Closed -$230K – 103
2016
Q3 		$230K Hold
8,400
– – 0.06% 85
2016
Q2 		$237K Buy
+8,400
New +$216K 0.07% 82
2015
Q3 		– Sell
-8,400
Closed -$207K – 89
2015
Q2 		$207K Sell
8,400
-200
-2% -$4.99K 0.05% 75
2015
Q1 		$216K Buy
+8,600
New +$204K 0.06% 71
2014
Q4 		– Sell
-16,476
Closed -$384K – 77
2014
Q3 		$384K Buy
+16,476
New +$386K 0.12% 44

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Accredited Investors's TECH Position: Q2 2026 in Review

Accredited Investors reduced its Bio-Techne (TECH) stake by 0.36% in Q2 2026, selling an estimated $1.08K and leaving 5,521 shares worth $390K. The position accounts for 0.02% of the portfolio, ranked #202.

Accredited Investors first reported a position in TECH in Q3 2014 and has held it in 19 quarters since. The position peaked at $482K in Q4 2023. 594 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Accredited Investors held 5,521 shares of Bio-Techne worth $390K as of Q2 2026.
  • Accredited Investors sold 20 Bio-Techne shares in Q2 2026, an estimated $1.08K.
  • Bio-Techne made up 0.02% of Accredited Investors's portfolio in Q2 2026, its #202 holding.
  • Accredited Investors first reported a position in Bio-Techne in Q3 2014 and has held it in 19 quarters since.
  • Accredited Investors's Bio-Techne position peaked at $482K in Q4 2023.
  • 594 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Accredited Investors's 13F filing for Q2 2026, filed 21 Jul 2026.